These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8640952

  • 1. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I).
    Hansson A, Hehenberger K, Thorén M.
    Cell Biochem Funct; 1996 Jun; 14(2):121-9. PubMed ID: 8640952
    [Abstract] [Full Text] [Related]

  • 2. Activation of MAP kinase in Swiss 3T3 fibroblasts by insulin-like growth factor-I.
    Hansson A, Thorén M.
    Growth Regul; 1995 Jun; 5(2):92-100. PubMed ID: 7627095
    [Abstract] [Full Text] [Related]

  • 3. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 4. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y, Akanuma Y, Yazaki Y, Kadowaki T.
    J Cell Physiol; 1999 Jan 01; 178(1):69-75. PubMed ID: 9886492
    [Abstract] [Full Text] [Related]

  • 5. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH, Fleming IN, Downes CP.
    Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130
    [Abstract] [Full Text] [Related]

  • 6. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
    Tsakiridis T, Tsiani E, Lekas P, Bergman A, Cherepanov V, Whiteside C, Downey GP.
    Biochem Biophys Res Commun; 2001 Oct 19; 288(1):205-11. PubMed ID: 11594774
    [Abstract] [Full Text] [Related]

  • 7. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 9. Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts.
    Xu XQ, McGuire TF, Blaskovich MA, Sebti SM, Romero G.
    Arch Biochem Biophys; 1996 Feb 15; 326(2):233-7. PubMed ID: 8611028
    [Abstract] [Full Text] [Related]

  • 10. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW, Xiao S, Pillay TS, Kolch W, Olefsky JM.
    Oncogene; 1998 Aug 20; 17(7):889-99. PubMed ID: 9780005
    [Abstract] [Full Text] [Related]

  • 11. Extracellular matrix induced by TGFbeta impairs insulin signal transduction in 3T3-L1 preadipose cells.
    Gagnon AM, Chabot J, Pardasani D, Sorisky A.
    J Cell Physiol; 1998 Jun 20; 175(3):370-8. PubMed ID: 9572482
    [Abstract] [Full Text] [Related]

  • 12. Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in Chinese hamster ovary cells.
    Kato H, Faria TN, Stannard B, Levy-Toledano R, Taylor SI, Roberts CT, LeRoith D.
    J Cell Physiol; 1993 Jul 20; 156(1):145-52. PubMed ID: 7686165
    [Abstract] [Full Text] [Related]

  • 13. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG, Blakesley VA, Stannard BS, LeRoith D.
    Endocrinology; 1997 Jun 20; 138(6):2552-8. PubMed ID: 9165048
    [Abstract] [Full Text] [Related]

  • 14. Insulin and IGF-I receptors signaling in protection from apoptosis.
    Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R.
    Horm Metab Res; 1999 Jun 20; 31(2-3):80-9. PubMed ID: 10226786
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of glucocorticoids on insulin-like growth factor I action in cultured human fibroblasts.
    Conover CA, Hintz RL, Johnson BF.
    J Cell Physiol; 1995 Jun 20; 163(3):615-22. PubMed ID: 7775603
    [Abstract] [Full Text] [Related]

  • 16. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
    Auclair M, Vigouroux C, Desbois-Mouthon C, Deibener J, Kaminski P, Lascols O, Cherqui G, Capeau J, Caron M.
    J Clin Endocrinol Metab; 1999 Sep 20; 84(9):3197-206. PubMed ID: 10487687
    [Abstract] [Full Text] [Related]

  • 17. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
    Brüning JC, Winnay J, Cheatham B, Kahn CR.
    Mol Cell Biol; 1997 Mar 20; 17(3):1513-21. PubMed ID: 9032279
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine protein kinase expression in long-term quiescent WI-38 cells following growth factor simulation.
    Korcz A, Soprano DR, Soprano KJ.
    J Cell Biochem; 1995 Sep 20; 59(1):42-52. PubMed ID: 8530535
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor I/somatomedin-C (IGF-I/SM-C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts.
    Conover CA, Dollar LA, Hintz RL, Rosenfeld RG.
    J Cell Physiol; 1983 Aug 20; 116(2):191-7. PubMed ID: 6306016
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis.
    Aleem E, Nehrbass D, Klimek F, Mayer D, Bannasch P.
    Toxicol Pathol; 2011 Apr 20; 39(3):524-43. PubMed ID: 21411721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.